Growth Metrics

CorMedix (CRMD) Consolidated Net Income: 2012-2025

Historic Consolidated Net Income for CorMedix (CRMD) over the last 12 years, with Sep 2025 value amounting to $108.6 million.

  • CorMedix's Consolidated Net Income rose 4002.28% to $108.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $163.0 million, marking a year-over-year increase of 496.27%. This contributed to the annual value of -$17.9 million for FY2024, which is 62.52% up from last year.
  • According to the latest figures from Q3 2025, CorMedix's Consolidated Net Income is $108.6 million, which was up 433.49% from $20.3 million recorded in Q2 2025.
  • CorMedix's 5-year Consolidated Net Income high stood at $108.6 million for Q3 2025, and its period low was -$14.5 million during Q1 2024.
  • In the last 3 years, CorMedix's Consolidated Net Income had a median value of -$6.3 million in 2023 and averaged $10.0 million.
  • As far as peak fluctuations go, CorMedix's Consolidated Net Income crashed by 60.27% in 2023, and later skyrocketed by 4,002.28% in 2025.
  • Quarterly analysis of 5 years shows CorMedix's Consolidated Net Income stood at -$7.8 million in 2021, then declined by 5.36% to -$8.2 million in 2022, then crashed by 42.18% to -$9.7 million in 2023, then skyrocketed by 71.45% to $13.5 million in 2024, then skyrocketed by 4,002.28% to $108.6 million in 2025.
  • Its Consolidated Net Income stands at $108.6 million for Q3 2025, versus $20.3 million for Q2 2025 and $20.6 million for Q1 2025.